Atika Capital Management »

Dyne Therapeutics shares owned by Atika Capital Management

Quarter-by-quarter ownership of Dyne Therapeutics (DYN) shares owned by Atika Capital Management from 13F filings

Historical chart of Atika Capital Management investment in Dyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dyne Therapeutics held by Atika Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dyne Therapeutics by Atika Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $5.0M 175k 28.39

More positions owned by Atika Capital Management

EXACT Sciences Corporation Call Option (EXAS)
Ishares Tr Rus Top 200 Etf Call Option (IWL)
NVIDIA Corporation (NVDA)
Shockwave Med
Microsoft Corporation (MSFT)
Vertiv Holdings Com Cl A (VRT)
Inspire Med Sys (INSP)
Amazon (AMZN)
MercadoLibre (MELI)
Eli Lilly & Co. (LLY)
Intuitive Surgical Com New (ISRG)
Rxsight (RXST)
Meta Platforms Cl A (META)
Sentinelone Cl A (S)
Appfolio Com Cl A (APPF)

View all positions for Atika Capital Management

Top funds holding Dyne Therapeutics

Atlas Venture Life Science Advisors
Fcpm Iii Services B.v.
BlackRock
BlackRock
RA Capital Management
Vanguard Group
Henderson Group
Deep Track Capital
State Street Corporation
Citadel Advisors
TCG Crossover Management
T. Rowe Price Associates
VR Adviser
Goldman Sachs Group
Holocene Advisors

View all funds holding Dyne Therapeutics